Study: less than half of pregnant people screened for HCV

By staff writers

June 13, 2022 -- A joint study conducted by Quest Diagnostics and the U.S. Centers for Disease Control and Prevention (CDC) has found that while the rate of hepatitis C (HCV) antibody screening increased 145% in pregnant people during the decade-long study period ending in June 2021, less than half of all pregnant people were screened in early 2021.

Quest noted that the CDC and the U.S. Preventive Services Task Force (USPSTF) published guidelines in early 2020 acknowledging the value of HCV antibody screening in response to growing rates of infection. A significant increase in screening was seen following the guidelines but many patients are still not receiving the recommended testing, Quest noted.

The new study found that nearly 41% of pregnant people received screening in early 2021.

The study, based on the deidentified results of more than 5 million pregnant people in the U.S., was recently published in Obstetrics & Gynecology.

Lucence promotes study of LiquidHallmark biopsy assay
Oncology company Lucence said a recent study in PLOS One has established the high sensitivity, specificity, accuracy, and precision of its LiquidHallmark...
10 reasons for growth in the market for infectious disease testing
While COVID-19 has placed the need for in vitro diagnostics (IVD) that can detect infectious diseases front and center, demand for these tests was building...
Co-Diagnostics joint venture approved for HCV test in India
Co-Diagnostics said its joint venture in India, CoSara Diagnostics, has received clearance to manufacture and sell its Saraq Hepatitis C (HCV) Viral Load...
Labs short on resources can use sequencing to ID pathogens
Countries with scarce laboratory resources could identify emerging pathogens by applying genomic sequencing of microbes to blood samples from patients....

Copyright © 2022

Last Updated mp 6/13/2022 10:27:03 AM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current